Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Clinical bloodstream isolate CUBIST-18 is part of the Cubist Pharmaceuticals Isolate Collection. CUBIST-18 is the daptomycin-resistant isolate of the CUBIST-17/CUBIST-18 sequential isolate paired strains obtained from a patient with endovascular staphylococcal infection following daptomycin treatment failure. It is multilocus sequence type 5, clonal complex 5, SCCmec-II (+), spa type t002 / T1-J1-M1-B1-M1-D1-M1-G1-M1-K1. Compared to CUBIST-17, CUBIST-18 has sequence variations in mprF (L341S) and in cls2 (R295C). It was previously described in a 2015 report as strain "C18".
BioProject SRA Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on